VERMILION ENERGY INC (VET.CA) Fundamental Analysis & Valuation

TSX:VET • CA9237251058

Current stock price

17.18 CAD
+0.32 (+1.9%)
Last:

This VET.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. VET.CA Profitability Analysis

1.1 Basic Checks

  • VET had negative earnings in the past year.
  • In the past year VET had a positive cash flow from operations.
  • In multiple years VET reported negative net income over the last 5 years.
  • Each year in the past 5 years VET had a positive operating cash flow.
VET.CA Yearly Net Income VS EBIT VS OCF VS FCFVET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • VET has a Return On Assets of -12.23%. This is in the lower half of the industry: VET underperforms 64.04% of its industry peers.
  • Looking at the Return On Equity, with a value of -29.42%, VET is doing worse than 61.58% of the companies in the same industry.
  • VET has a Return On Invested Capital of 2.66%. This is comparable to the rest of the industry: VET outperforms 55.17% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for VET is below the industry average of 6.97%.
Industry RankSector Rank
ROA -12.23%
ROE -29.42%
ROIC 2.66%
ROA(3y)-5.6%
ROA(5y)4.29%
ROE(3y)-12.97%
ROE(5y)11.06%
ROIC(3y)2.94%
ROIC(5y)8.19%
VET.CA Yearly ROA, ROE, ROICVET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • The Operating Margin of VET (9.59%) is comparable to the rest of the industry.
  • VET's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 67.50%, VET belongs to the best of the industry, outperforming 81.77% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VET has grown nicely.
Industry RankSector Rank
OM 9.59%
PM (TTM) N/A
GM 67.5%
OM growth 3Y-44.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y5.3%
VET.CA Yearly Profit, Operating, Gross MarginsVET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VET.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VET is destroying value.
  • The number of shares outstanding for VET has been reduced compared to 1 year ago.
  • The number of shares outstanding for VET has been reduced compared to 5 years ago.
  • Compared to 1 year ago, VET has a worse debt to assets ratio.
VET.CA Yearly Shares OutstandingVET.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VET.CA Yearly Total Debt VS Total AssetsVET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.42, we must say that VET is in the distress zone and has some risk of bankruptcy.
  • VET has a Altman-Z score of 0.42. This is in the lower half of the industry: VET underperforms 60.59% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that VET is somewhat dependend on debt financing.
  • VET has a Debt to Equity ratio of 0.58. This is comparable to the rest of the industry: VET outperforms 49.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.42
ROIC/WACC0.33
WACC8.09%
VET.CA Yearly LT Debt VS Equity VS FCFVET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • VET has a Current Ratio of 0.84. This is a bad value and indicates that VET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VET's Current ratio of 0.84 is in line compared to the rest of the industry. VET outperforms 57.14% of its industry peers.
  • A Quick Ratio of 0.76 indicates that VET may have some problems paying its short term obligations.
  • VET has a Quick ratio of 0.76. This is comparable to the rest of the industry: VET outperforms 56.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.76
VET.CA Yearly Current Assets VS Current LiabilitesVET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. VET.CA Growth Analysis

3.1 Past

  • VET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1316.67%.
  • The Revenue has decreased by -2.65% in the past year.
  • The Revenue has been growing by 9.12% on average over the past years. This is quite good.
EPS 1Y (TTM)-1316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2283.33%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y-19.75%
Revenue growth 5Y9.12%
Sales Q2Q%26.17%

3.2 Future

  • VET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.13% yearly.
  • VET is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.89% yearly.
EPS Next Y102.97%
EPS Next 2Y46.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.19%
Revenue Next 2Y0.05%
Revenue Next 3Y1.92%
Revenue Next 5Y0.89%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VET.CA Yearly Revenue VS EstimatesVET.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
VET.CA Yearly EPS VS EstimatesVET.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

2

4. VET.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • VET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 136.08, which means the current valuation is very expensive for VET.
  • VET's Price/Forward Earnings is on the same level as the industry average.
  • VET is valuated expensively when we compare the Price/Forward Earnings ratio to 22.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 136.08
VET.CA Price Earnings VS Forward Price EarningsVET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VET is valued cheaper than 92.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.24
VET.CA Per share dataVET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VET's earnings are expected to grow with 46.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. VET.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.07%, VET has a reasonable but not impressive dividend return.
  • VET's Dividend Yield is a higher than the industry average which is at 3.03.
  • Compared to an average S&P500 Dividend Yield of 1.82, VET pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.07%

5.2 History

  • The dividend of VET decreases each year by -3.03%.
  • VET has paid a dividend for at least 10 years, which is a reliable track record.
  • VET has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.03%
Div Incr Years3
Div Non Decr Years3
VET.CA Yearly Dividends per shareVET.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of VET are negative and hence is the payout ratio. VET will probably not be able to sustain this dividend level.
DP-15.06%
EPS Next 2Y46.13%
EPS Next 3YN/A
VET.CA Yearly Income VS Free CF VS DividendVET.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

VET.CA Fundamentals: All Metrics, Ratios and Statistics

VERMILION ENERGY INC

TSX:VET (4/27/2026, 7:00:00 PM)

17.18

+0.32 (+1.9%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners60.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap2.62B
Revenue(TTM)1.85B
Net Income(TTM)-653.60M
Analysts69.33
Price Target17.53 (2.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.07%
Yearly Dividend0.64
Dividend Growth(5Y)-3.03%
DP-15.06%
Div Incr Years3
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-913.05%
Min EPS beat(2)-1765.7%
Max EPS beat(2)-60.4%
EPS beat(4)0
Avg EPS beat(4)-913.27%
Min EPS beat(4)-1768.81%
Max EPS beat(4)-58.17%
EPS beat(8)0
Avg EPS beat(8)-518.9%
EPS beat(12)2
Avg EPS beat(12)-406.34%
EPS beat(16)4
Avg EPS beat(16)857.14%
Revenue beat(2)1
Avg Revenue beat(2)-3.71%
Min Revenue beat(2)-17.37%
Max Revenue beat(2)9.96%
Revenue beat(4)1
Avg Revenue beat(4)-9.65%
Min Revenue beat(4)-26.83%
Max Revenue beat(4)9.96%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)1
Avg Revenue beat(12)-10.33%
Revenue beat(16)4
Avg Revenue beat(16)-2.99%
PT rev (1m)18.12%
PT rev (3m)23.13%
EPS NQ rev (1m)-7.81%
EPS NQ rev (3m)-10.61%
EPS NY rev (1m)-72.02%
EPS NY rev (3m)-79.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)-0.92%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 136.08
P/S 1.42
P/FCF N/A
P/OCF 2.78
P/B 1.18
P/tB 1.18
EV/EBITDA 4.24
EPS(TTM)-4.25
EYN/A
EPS(NY)0.13
Fwd EY0.73%
FCF(TTM)-5.11
FCFYN/A
OCF(TTM)6.18
OCFY35.99%
SpS12.1
BVpS14.56
TBVpS14.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -12.23%
ROE -29.42%
ROCE 3.7%
ROIC 2.66%
ROICexc 2.67%
ROICexgc 2.67%
OM 9.59%
PM (TTM) N/A
GM 67.5%
FCFM N/A
ROA(3y)-5.6%
ROA(5y)4.29%
ROE(3y)-12.97%
ROE(5y)11.06%
ROIC(3y)2.94%
ROIC(5y)8.19%
ROICexc(3y)3%
ROICexc(5y)8.24%
ROICexgc(3y)3%
ROICexgc(5y)8.24%
ROCE(3y)4.08%
ROCE(5y)11.37%
ROICexgc growth 3Y-52.06%
ROICexgc growth 5YN/A
ROICexc growth 3Y-52.06%
ROICexc growth 5YN/A
OM growth 3Y-44.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y5.3%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 231.87%
Cap/Sales 93.37%
Interest Coverage 1.35
Cash Conversion 102.52%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.76
Altman-Z 0.42
F-Score5
WACC8.09%
ROIC/WACC0.33
Cap/Depr(3y)142.57%
Cap/Depr(5y)140.06%
Cap/Sales(3y)58.41%
Cap/Sales(5y)46.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2283.33%
EPS Next Y102.97%
EPS Next 2Y46.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y-19.75%
Revenue growth 5Y9.12%
Sales Q2Q%26.17%
Revenue Next Year-3.19%
Revenue Next 2Y0.05%
Revenue Next 3Y1.92%
Revenue Next 5Y0.89%
EBIT growth 1Y-25.05%
EBIT growth 3Y-55.8%
EBIT growth 5YN/A
EBIT Next Year116.51%
EBIT Next 3Y37.44%
EBIT Next 5YN/A
FCF growth 1Y-334.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.49%
OCF growth 3Y-19.58%
OCF growth 5Y13.54%

VERMILION ENERGY INC / VET.CA Fundamental Analysis FAQ

What is the fundamental rating for VET stock?

ChartMill assigns a fundamental rating of 3 / 10 to VET.CA.


What is the valuation status of VERMILION ENERGY INC (VET.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to VERMILION ENERGY INC (VET.CA). This can be considered as Overvalued.


Can you provide the profitability details for VERMILION ENERGY INC?

VERMILION ENERGY INC (VET.CA) has a profitability rating of 3 / 10.


Is the dividend of VERMILION ENERGY INC sustainable?

The dividend rating of VERMILION ENERGY INC (VET.CA) is 4 / 10 and the dividend payout ratio is -15.06%.